Primary Site >> Stomach Cancer
Gene >> FOXM1
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|
|
Ref: Identification and characterization of rat Desert hedgehog and Indian hedgehog genes in silico. PMID: 15645142 Ref: Hedgehog signaling pathway and gastric cancer. PMID: 16258256 |
Ref: FoxM1 is up-regulated in gastric cancer and its inhibition leads to cellular senescence, partially dependent on p27 kip1. PMID: 19235838 Ref: Critical role and regulation of transcription factor FoxM1 in human gastric cancer angiogenesis and progression. PMID: 19351851 Ref: Hedgehog target genes: mechanisms of carcinogenesis induced by aberrant hedgehog signaling activation. PMID: 19860666 |
Ref: Disruption of Klf4 in villin-positive gastric progenitor cells promotes formation and progression of tumors of the antrum in mice. PMID: 22155367 Ref: 7-difluoromethoxyl-5,4'-di-n-octylgenistein inhibits growth of gastric cancer cells through downregulating forkhead box M1. PMID: 22969238 |
Ref: Overexpression of forkhead box M1 transcription factor (FOXM1) is a potential prognostic marker and enhances chemoresistance for docetaxel in gastric cancer. PMID: 23054116 Ref: FoxM1 is overexpressed in Helicobacter pylori-induced gastric carcinogenesis and is negatively regulated by miR-370. PMID: 23576572 Ref: Forkhead box transcription factor 1 expression in gastric cancer: FOXM1 is a poor prognostic factor and mediates resistance to docetaxel. PMID: 24004449 Ref: Twist1 promotes gastric cancer cell proliferation through up-regulation of FoxM1. PMID: 24204899 Ref: Transcriptomic changes induced by mycophenolic acid in gastric cancer cells. PMID: 24349619 |
Ref: Overexpressed transcription factor FOXM1 is a potential diagnostic and adverse prognostic factor in postoperational gastric cancer patients. PMID: 23873251 Ref: Clinical significance and positive correlation of FoxM1 and Her-2 expression in gastric cancer. PMID: 24101296 Ref: FOXM1 mediates resistance to docetaxel in gastric cancer via up-regulating Stathmin. PMID: 24628949 Ref: Overexpression of Her-2 upregulates FoxM1 in gastric cancer. PMID: 24715000 Ref: Down-regulation of FoxM1 leads to the inhibition of the epithelial-mesenchymal transition in gastric cancer cells. PMID: 24726291 Ref: MicroRNA-194 inhibits the epithelial-mesenchymal transition in gastric cancer cells by targeting FoxM1. PMID: 24748184 |
Ref: The FOXM1-induced resistance to oxaliplatin is partially mediated by its novel target gene Mcl-1 in gastric cancer cells. PMID: 25482013 Ref: High-level SAE2 promotes malignant phenotype and predicts outcome in gastric cancer. PMID: 25628926 Ref: 3,3'-Diindolylmethane potentiates paclitaxel-induced antitumor effects on gastric cancer cells through the Akt/FOXM1 signaling cascade. PMID: 25633416 Ref: A FOXM1 related long non-coding RNA contributes to gastric cancer cell migration. PMID: 25907137 Ref: High-level SAE2 promotes malignant phenotype and predicts outcome in gastric cancer. PMID: 25973299 Ref: FOXM1 and its Oncogenic Signaling in Gastric Cancer. PMID: 26081924 Ref: SUMO-specific protease 6 promotes gastric cancer cell growth via deSUMOylation of FoxM1. PMID: 26164001 Ref: LncRNA-AP001631.9 promotes cell migration in gastric cancer. PMID: 26261500 Ref: FOXM1-LDHA signaling promoted gastric cancer glycolytic phenotype and progression. PMID: 26261559 Ref: Prognostic Value of FOXM1 in Patients with Malignant Solid Tumor: A Meta-Analysis and System Review. PMID: 26451068 Ref: FOXM1 and polo-like kinase 1 are co-ordinately overexpressed in patients with gastric adenocarcinomas. PMID: 26576650 |
Ref: F-box protein FBXL2 inhibits gastric cancer proliferation by ubiquitin-mediated degradation of forkhead box M1. PMID: 26790640 Ref: Trichostatin A potentiates TRAIL-induced antitumor effects via inhibition of ERK/FOXM1 pathway in gastric cancer. PMID: 26831669 Ref: MiR-320a inhibits gastric carcinoma by targeting activity in the FoxM1-P27KIP1 axis. PMID: 27086911 Ref: Depletion of FOXM1 via MET Targeting Underlies Establishment of a DNA Damage-Induced Senescence Program in Gastric Cancer. PMID: 27185371 Ref: Identification of Glypican-3 as a potential metastasis suppressor gene in gastric cancer. PMID: 27259271 Ref: 7-Difluoromethoxyl-5,4'-di-n-octyl genistein inhibits the stem-like characteristics of gastric cancer stem-like cells and reverses the phenotype of epithelial-mesenchymal transition in gastric cancer cells. PMID: 27279287 Ref: Knockdown of the FoxM1 enhances the sensitivity of gastric cancer cells to cisplatin by targeting Mcl-1. PMID: 27455555 Ref: Expression of FoxM1 and the EMT-associated protein E-cadherin in gastric cancer and its clinical significance. PMID: 27698811 Ref: miR-149 reverses cisplatin resistance of gastric cancer SGC7901/DDP cells by targeting FoxM1. PMID: 29441968 |
Ref: hTERT promotes the invasion of gastric cancer cells by enhancing FOXO3a ubiquitination and subsequent ITGB1 upregulation. PMID: 26370108 Ref: A Positive Feedback Loop of lncRNA-PVT1 and FOXM1 Facilitates Gastric Cancer Growth and Invasion. PMID: 27756785 Ref: Transcriptional Regulatory Network Analysis for Gastric Cancer Based on mRNA Microarray. PMID: 28078605 Ref: Basic Transcription Factor 3 Is Required for Proliferation and Epithelial-Mesenchymal Transition via Regulation of FOXM1 and JAK2/STAT3 Signaling in Gastric Cancer. PMID: 28276310 Ref: Integrated expression analysis identifies transcription networks in mouse and human gastric neoplasia. PMID: 28281307 Ref: Multiple therapeutic peptide vaccines for patients with advanced gastric cancer. PMID: 28393243 Ref: Prognostic value of FOXM1 in solid tumors: a systematic review and meta-analysis. PMID: 28427178 Ref: MicroRNA-630 Suppresses Epithelial-to-Mesenchymal Transition by Regulating FoxM1 in Gastric Cancer Cells. PMID: 28601080 Ref: A Pilot Study of Post-Operative Adjuvant Vaccine for Advanced Gastric Cancer. PMID: 28701892 Ref: FOXM1 facilitates gastric cancer cell migration and invasion by inducing Cathepsin D. PMID: 28978107 Ref: Clinicopathological and prognostic significance of FoxM1 in gastric cancer: A meta-analysis. PMID: 29017864 Ref: ADAM-17 expression is enhanced by FoxM1 and is a poor prognostic sign in gastric carcinoma. PMID: 29180185 Ref: Overexpression of forkhead box M1 and urokinase-type plasminogen activator in gastric cancer is associated with cancer progression and poor prognosis. PMID: 29344165 |
Ref: Elevated O-GlcNAcylation stabilizes FOXM1 by its reduced degradation through GSK-3beta inactivation in a human gastric carcinoma cell line, MKN45 cells. PMID: 29196265 Ref: Clinical prognostic value of A FOXM1 related long non-coding RNA expression in gastric cancer. PMID: 29424899 Ref: MiR-361-5p suppresses chemoresistance of gastric cancer cells by targeting FOXM1 via the PI3K/Akt/mTOR pathway. PMID: 29435149 Ref: Multilayered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/betacatenin signaling activation (Review). PMID: 29786110 Ref: Tight correlation between FoxM1 and FoxP3+ Tregs in gastric cancer and their clinical significance. PMID: 29804142 Ref: PARI functions as a new transcriptional target of FOXM1 involved in gastric cancer development. PMID: 29805304 Ref: Silencing forkhead box M1 promotes apoptosis and autophagy through SIRT7/mTOR/IGF2 pathway in gastric cancer cells. PMID: 29953672 Ref: Paired box 8 suppresses tumor angiogenesis and metastasis in gastric cancer through repression of FOXM1 via induction of microRNA-612. PMID: 30021604 Ref: SPDEF is overexpressed in gastric cancer and triggers cell proliferation by forming a positive regulation loop with FoxM1. PMID: 30076647 Ref: Long non-coding RNA CCAL/miR-149/FOXM1 axis promotes metastasis in gastric cancer. PMID: 30250169 Ref: Clinical significance and biological roles of cyclins in gastric cancer. PMID: 30349301 |